Cargando…
Gain of chromosome 21 in hematological malignancies: lessons from studying leukemia in children with Down syndrome
Structural and numerical alterations of chromosome 21 are extremely common in hematological malignancies. While the functional impact of chimeric transcripts from fused chromosome 21 genes such as TEL-AML1, AML1-ETO, or FUS-ERG have been extensively studied, the role of gain of chromosome 21 remains...
Autores principales: | Laurent, Anouchka P., Kotecha, Rishi S., Malinge, Sébastien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387246/ https://www.ncbi.nlm.nih.gov/pubmed/32433508 http://dx.doi.org/10.1038/s41375-020-0854-5 |
Ejemplares similares
-
COVID-19 Infection in Children with Down Syndrome and Hematologic Malignancies
por: Foxworthy, Blake, et al.
Publicado: (2022) -
Characterization of mesenchymal stem cells in pre-B acute lymphoblastic leukemia
por: Hughes, Anastasia M., et al.
Publicado: (2023) -
Chromosome Territories in Hematological Malignancies
por: de Lima, Matheus Fabiao, et al.
Publicado: (2022) -
Molecular Genetics of Chromosome 21 and Down Syndrome
por: Seashore, Margretta R.
Publicado: (1991) -
Heritable variation at the chromosome 21 gene ERG is associated with acute lymphoblastic leukemia risk in children with and without Down syndrome
por: de Smith, Adam J., et al.
Publicado: (2019)